203 related articles for article (PubMed ID: 12916937)
1. Double-layered mucoadhesive tablets containing nystatin.
Llabot JM; Manzo RH; Allemandi DA
AAPS PharmSciTech; 2002; 3(3):E22. PubMed ID: 12916937
[TBL] [Abstract][Full Text] [Related]
2. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin.
Hombach J; Palmberger TF; Bernkop-Schnürch A
J Pharm Sci; 2009 Feb; 98(2):555-64. PubMed ID: 18563796
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation.
Sakeer K; Al-Zein H; Hassan I; Desai S; Nokhodchi A
Arch Pharm Res; 2010 Nov; 33(11):1771-9. PubMed ID: 21116780
[TBL] [Abstract][Full Text] [Related]
4. Effect of excipient and processing variables on adhesive properties and release profile of pentoxifylline from mucoadhesive tablets.
Surapaneni MS; Das SK; Das NG
Drug Dev Ind Pharm; 2006 Mar; 32(3):377-87. PubMed ID: 16556542
[TBL] [Abstract][Full Text] [Related]
5. Gum Ghatti--a pharmaceutical excipient: development, evaluation and optimization of sustained release mucoadhesive matrix tablets of domperidone.
Gurpreetarora ; Malik K; Rana V; Singh I
Acta Pol Pharm; 2012; 69(4):725-37. PubMed ID: 22876617
[TBL] [Abstract][Full Text] [Related]
6. Optimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson's disease: physical characterization and ex vivo drug permeation through buccal mucosa.
Çelik B; Özdemir S; Barla Demirkoz A; Üner M
Drug Dev Ind Pharm; 2017 Nov; 43(11):1836-1845. PubMed ID: 28665152
[TBL] [Abstract][Full Text] [Related]
7. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
Van Nguyen H; Nguyen VH; Lee BJ
Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
[TBL] [Abstract][Full Text] [Related]
8. Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique.
Cao QR; Liu Y; Xu WJ; Lee BJ; Yang M; Cui JH
Int J Pharm; 2012 Sep; 434(1-2):325-33. PubMed ID: 22688251
[TBL] [Abstract][Full Text] [Related]
9. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
[TBL] [Abstract][Full Text] [Related]
10. Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance.
Llabot JM; Manzo RH; Allemandi DA
J Pharm Sci; 2009 May; 98(5):1871-6. PubMed ID: 18803261
[TBL] [Abstract][Full Text] [Related]
11. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
12. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
Košir D; Vrečer F
Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
[TBL] [Abstract][Full Text] [Related]
13. Design of novel antifungal mucoadhesive films. Part II. Formulation and in vitro biopharmaceutical evaluation.
Llabot JM; Palma SD; Manzo RH; Allemandi DA
Int J Pharm; 2007 May; 336(2):263-8. PubMed ID: 17223291
[TBL] [Abstract][Full Text] [Related]
14. [Effect of release of hydroxypropylmethyl cellulose on single and bilayer sustained-release matrix tablets].
Yang YP; Wang MY; Chang JB; Guo MT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):291-6. PubMed ID: 23591354
[TBL] [Abstract][Full Text] [Related]
15. Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.
Gohel M; Bariya SH
Pharm Dev Technol; 2009; 14(6):650-8. PubMed ID: 19883254
[TBL] [Abstract][Full Text] [Related]
16. Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system.
Llabot JM; Manzo RH; Allemandi DA
Int J Pharm; 2004 May; 276(1-2):59-66. PubMed ID: 15113614
[TBL] [Abstract][Full Text] [Related]
17. Mucoadhesive tablets for controlled release of acyclovir.
Ruiz-Caro R; Gago-Guillan M; Otero-Espinar FJ; Veiga MD
Chem Pharm Bull (Tokyo); 2012; 60(10):1249-57. PubMed ID: 22863800
[TBL] [Abstract][Full Text] [Related]
18. Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer.
Gonzalez YM; Ghaly ES
Drug Dev Ind Pharm; 2010 Jan; 36(1):64-71. PubMed ID: 19747067
[TBL] [Abstract][Full Text] [Related]
19. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
Wang MY; Yang YP; Chang JB; Guo MT
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
[TBL] [Abstract][Full Text] [Related]
20. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis.
Ferrero C; Massuelle D; Doelker E
J Control Release; 2010 Jan; 141(2):223-33. PubMed ID: 19766681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
